Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:MYL
Tag: NASDAQ:MYL
Mylan N.V. (NASDAQ:MYL) To Pay New Hampshire $1 Million Over EpiPen...
-
August 21, 2017
0
Mylan N.V. (NASDAQ:MYL) reported earnings of $1.10 per share missing Walls...
ME Staff
-
August 9, 2017
0
Huge Debt Burden Hinders Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Mylan...
Andy Parker
-
August 7, 2017
0
Biotech Movers: TESARO Inc (NASDAQ:TSRO) and Mylan N.V. (NASDAQ:MYL)
-
July 14, 2017
0
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) Ready To Disrupt Mylan N.V. (NASDAQ:MYL) EpiPen...
Andy Parker
-
June 20, 2017
0
Mylan N.V. (NASDAQ:MYL) Says It Disagrees With FDA Decision On Generic...
Andy Parker
-
May 11, 2017
0
Mylan N.V. (NASDAQ:MYL) Epipen Still Effective After 29 Months Post Expiration
-
May 10, 2017
0
Mylan N.V. (NASDAQ:MYL) Is Served With A Warning Letter Over Integrity...
Andy Parker
-
April 12, 2017
0
Mylan N.V. (NASDAQ:MYL) Given Go-Ahead For Angiomax In Blow To Medicines...
Andy Parker
-
April 7, 2017
0
Advair Generic Developed By Mylan NV (NASDAQ:MYL) Rejected By The FDA
-
March 30, 2017
0
1
2
3
4
Page 2 of 4
/* */
// AST – IMS - [MarketExclusive_ROS]
Edit with Live CSS